Profound Medical (PROF) Debt to Equity (2018 - 2026)
Profound Medical has reported Debt to Equity over the past 7 years, most recently at $0.07 for Q4 2025.
- For Q4 2025, Debt to Equity fell 12.21% year-over-year to $0.07; the TTM value through Dec 2025 reached $0.07, down 12.21%, while the annual FY2025 figure was $0.07, 12.21% down from the prior year.
- Debt to Equity for Q4 2025 was $0.07 at Profound Medical, down from $0.14 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.23 in Q4 2023 and troughed at $0.0 in Q1 2022.
- A 5-year average of $0.1 and a median of $0.11 in 2024 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: surged 516907.31% in 2023 and later plummeted 66.09% in 2024.
- Year by year, Debt to Equity stood at $0.02 in 2021, then skyrocketed by 678.75% to $0.14 in 2022, then soared by 66.81% to $0.23 in 2023, then plummeted by 66.09% to $0.08 in 2024, then fell by 12.21% to $0.07 in 2025.
- Business Quant data shows Debt to Equity for PROF at $0.07 in Q4 2025, $0.14 in Q3 2025, and $0.11 in Q2 2025.